Abstract
Toxic and drug-induced myopathies as a group may represent the most common form of myopathy with an estimated prevalence of more than 2,000 per 100,000 population in the Western Hemisphere. Patients with these myopathies often present to physicians who do not have the expertise of neuromuscular specialists. Failure to recognize the often-iatrogenic nature of these disorders and thus continue to expose the patient to the drug or toxin can unnecessarily prolong morbidity and lead to potentially fatal outcomes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Peters, S., Kley, R.A. (2013). Toxic and Drug-Induced Myopathies. In: Wattjes, M., Fischer, D. (eds) Neuromuscular Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6552-2_27
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6552-2_27
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6551-5
Online ISBN: 978-1-4614-6552-2
eBook Packages: MedicineMedicine (R0)